Utilization of community pharmacy space to enhance privacy: a qualitative study

Abstract

BackgroundCommunity pharmacists require access to consumers’ information about their medicines and health‐related conditions to make informed decisions regarding treatment options. Open communication between consumers and pharmacists is ideal although consumers are only likely to disclose relevant information if they feel that their privacy requirements are being acknowledged and adhered to.ObjectiveThis study sets out to explore community pharmacy privacy practices, experiences and expectations and the utilization of available space to achieve privacy.MethodsQualitative methods were used, comprising a series of face‐to‐face interviews with 25 pharmacists and 55 pharmacy customers in Perth, Western Australia, between June and August 2013.ResultsThe use of private consultation areas for certain services and sensitive discussions was supported by pharmacists and consumers although there was recognition that workflow processes in some pharmacies may need to change to maximize the use of private areas. Pharmacy staff adopted various strategies to overcome privacy obstacles such as taking consumers to a quieter part of the pharmacy, avoiding exposure of sensitive items through packaging, lowering of voices, interacting during pharmacy quiet times and telephoning consumers. Pharmacy staff and consumers regularly had to apply judgement to achieve the required level of privacy.DiscussionManagement of privacy can be challenging in the community pharmacy environment, and on‐going work in this area is important. As community pharmacy practice is increasingly becoming more involved in advanced medication and disease state management services with unique privacy requirements, pharmacies’ layouts and systems to address privacy challenges require a proactive approach.

The impact of a pharmacist-extender training program to improve pneumococcal vaccination rates within a community chain pharmacy

“…An Australian study used semistructured interviews to explore use of pharmacy space to enhance patient privacy in community pharmacy practice. 19 Similarly, a qualitative study on parental acceptance of human papillomavirus vaccinations supports the use of explanatory research in our study to help identify barriers and facilitators associated with implementation of the vaccination program. 20 The results from our study provide further knowledge and insight on the key differences between successful and unsuccessful implementation of the vaccine screening program.…”

Australian mental health consumers and carers expect more health management information from community pharmacy

“…Approaches to improve services include reducing negative attitudes towards mental illness and increasing awareness of the value of medication counselling . Consistent with previous findings, participants were interested in easy‐to‐understand, relevant treatment information, with clear and comprehensive medication labelling, delivered in a respectful and sensitive manner while considering consumer privacy …”

Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK

“…Nonetheless, pharmacists’ and GPs’ attitudes towards extended services in this review reflected international findings, where pharmacists in North America, Asia, Australasia, South America and Europe were also enthusiastic towards the concept of providing extended services (Dosea et al., ; Fang, Yang, Feng, Ni, & Zhang, ; Kinsey, Scahill, Bye, & Harrison, ; Kjome, Sandberg, & Granas, ; Schindel et al., ). Moreover, lack of awareness (Bjorkman, Viberg, Rydberg, & Stalsby Lundborg, ; Fakih, Marriott, & Hussainy, ; Freeman, Cottrell, Kyle, Williams, & Nissen, ; Wibowo, Sunderland, & Hughes, ), issues with community pharmacy premises (Babiker, Carson, & Awaisu, ; Bjorkman et al., ; Donald et al., ; Gray, Chamberlain, & Morris, ; Hattingh, Emmerton, Ng Cheong Tin, & Green, ; Murphy et al., ), lack of management support (Casserlie & Mager, ; Donald et al., ; Kinsey et al., ; Tsao et al., ; Watkins, McKee, Hughes, & Pfeiffenberger, ) and remuneration (Donald et al., ; Gray et al., ; Kinsey et al., ; Watkins et al., ) have also been found in other countries. Many pharmacists elsewhere also stressed the need for sufficient pharmacy staff (Casserlie & Mager, ; Gray et al., ; Kinsey et al., ; Murphy et al., ; Tsao et al., ), and pharmacists’(Donald et al., ; Jorgenson, Laubscher, Lyons, & Palmer, ; Watkins et al., ; Wibowo et al., ) and GPs’ (Bryant, Coster, Gamble, & McCormick, ; Dhillon et al., ; Tan, Stewart, Elliott, & George, ) views confirmed poor engagement between pharmacists and GPs.…”